Literature DB >> 24277439

Real-world impact of neurocognitive deficits in acute and early HIV infection.

Katie L Doyle1, Erin E Morgan, Sheldon Morris, Davey M Smith, Susan Little, Jennifer E Iudicello, Kaitlin Blackstone, David J Moore, Igor Grant, Scott L Letendre, Steven Paul Woods.   

Abstract

The acute and early period of HIV-1 infection (AEH) is characterized by neuroinflammatory and immunopathogenic processes that can alter the integrity of neural systems and neurocognitive functions. However, the extent to which central nervous system changes in AEH confer increased risk of real-world functioning (RWF) problems is not known. In the present study, 34 individuals with AEH and 39 seronegative comparison participants completed standardized neuromedical, psychiatric, and neurocognitive research evaluations, alongside a comprehensive assessment of RWF that included cognitive symptoms in daily life, basic and instrumental activities of daily living, clinician-rated global functioning, and employment. Results showed that AEH was associated with a significantly increased risk of dependence in RWF, which was particularly elevated among AEH persons with global neurocognitive impairment (NCI). Among those with AEH, NCI (i.e., deficits in learning and information processing speed), mood disorders (i.e., Bipolar Disorder), and substance dependence (e.g., methamphetamine dependence) were all independently predictive of RWF dependence. Findings suggest that neurocognitively impaired individuals with AEH are at notably elevated risk of clinically significant challenges in normal daily functioning. Screening for neurocognitive, mood, and substance use disorders in AEH may facilitate identification of individuals at high risk of functional dependence who may benefit from psychological and medical strategies to manage their neuropsychiatric conditions.

Entities:  

Mesh:

Year:  2013        PMID: 24277439      PMCID: PMC3865175          DOI: 10.1007/s13365-013-0218-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  44 in total

1.  The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.

Authors:  Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

2.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

3.  Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast.

Authors:  K Whetten; S Reif; J Ostermann; B W Pence; M Swartz; R Whetten; C Conover; S Bouis; N Thielman; J Eron
Journal:  AIDS Care       Date:  2006

4.  Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.

Authors:  I B Wilson; P D Cleary
Journal:  JAMA       Date:  1995-01-04       Impact factor: 56.272

5.  Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection.

Authors:  M R Lentz; W K Kim; V Lee; S Bazner; E F Halpern; N Venna; K Williams; E S Rosenberg; R G González
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

6.  HIV-associated prospective memory impairment increases risk of dependence in everyday functioning.

Authors:  Steven Paul Woods; Jennifer E Iudicello; Lisa M Moran; Catherine L Carey; Matthew S Dawson; Igor Grant
Journal:  Neuropsychology       Date:  2008-01       Impact factor: 3.295

7.  Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory.

Authors:  Steven Paul Woods; Matthew S Dawson; Erica Weber; Sarah Gibson; Igor Grant; J Hampton Atkinson
Journal:  J Int Neuropsychol Soc       Date:  2009-01       Impact factor: 2.892

8.  Early viral brain invasion in iatrogenic human immunodeficiency virus infection.

Authors:  L E Davis; B L Hjelle; V E Miller; D L Palmer; A L Llewellyn; T L Merlin; S A Young; R G Mills; W Wachsman; C A Wiley
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

9.  Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

Authors:  B M Ances; D Sisti; F Vaida; C L Liang; O Leontiev; J E Perthen; R B Buxton; D Benson; D M Smith; S J Little; D D Richman; D J Moore; R J Ellis
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  28 in total

1.  Apathy is associated with lower mental and physical quality of life in persons infected with HIV.

Authors:  Rujvi Kamat; Steven Paul Woods; Marizela V Cameron; Jennifer E Iudicello
Journal:  Psychol Health Med       Date:  2016-01-19       Impact factor: 2.423

Review 2.  Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?

Authors:  Wilbert Zwart; Huub Terra; Sabine C Linn; Sanne B Schagen
Journal:  Nat Rev Clin Oncol       Date:  2015-07-21       Impact factor: 66.675

3.  Habitual prospective memory in HIV disease.

Authors:  Katie L Doyle; Erica Weber; Erin E Morgan; Shayne Loft; Clint Cushman; Javier Villalobos; Elaine Johnston; Steven Paul Woods
Journal:  Neuropsychology       Date:  2015-03-02       Impact factor: 3.295

4.  The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.

Authors:  Joseph D Harrison; Jessica A Dochney; Sonja Blazekovic; Frank Leone; David Metzger; Ian Frank; Robert Gross; Anita Hole; Karam Mounzer; Steven Siegel; Robert A Schnoll; Rebecca L Ashare
Journal:  J Neurovirol       Date:  2017-04-20       Impact factor: 2.643

5.  Does Age Influence the Frequency of Anxiety Symptoms and Disorders in HIV Disease?

Authors:  Charles P Brandt; David P Sheppard; Michael J Zvolensky; Erin E Morgan; J Hampton Atkinson; Steven Paul Woods
Journal:  J HIV AIDS Soc Serv       Date:  2016-06-28

Review 6.  Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Authors:  Virawudh Soontornniyomkij; James P Kesby; Erin E Morgan; Amanda Bischoff-Grethe; Arpi Minassian; Gregory G Brown; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-02       Impact factor: 4.147

7.  Cognitive function in early HIV infection.

Authors:  Aanchal Prakash; Jue Hou; Lei Liu; Yi Gao; Casey Kettering; Ann B Ragin
Journal:  J Neurovirol       Date:  2016-11-28       Impact factor: 2.643

8.  Structural connectome differences in HIV infection: brain network segregation associated with nadir CD4 cell count.

Authors:  Ryan P Bell; Laura L Barnes; Sheri L Towe; Nan-Kuei Chen; Allen W Song; Christina S Meade
Journal:  J Neurovirol       Date:  2018-04-23       Impact factor: 2.643

9.  Operationalizing and evaluating the Frascati criteria for functional decline in diagnosing HIV-associated neurocognitive disorders in adults.

Authors:  Anastasia Matchanova; Steven Paul Woods; Victoria M Kordovski
Journal:  J Neurovirol       Date:  2019-11-19       Impact factor: 2.643

Review 10.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.